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Objective. This study was conducted to determine whether
Doppler recording of superior vena cava flow velocities can
differentiate chronic obstructive pulmonary disease from constric-
tive pericarditis in patients with a respiratory variation of >225%
in mitral inflow E velocity.
Background. Although respiratory variation (>225%) in mitral
E velocity is the main diagnostic criterion for constrictive peri-
carditis by Doppler echocardiography, it can also be present in
chronic obstructive pulmonary disease. Because the respiratory
variation is due to increased change in intrathoracic pressure with
respiration in chronic obstructive pulmonary disease, and to
dissociation of intrathoracic-intracardiac pressure changes in
constriction, it was hypothesized that the Doppler flow velocity
pattern in the superior vena cava (affected by intrathoracic
pressure) would be different in these two conditions.
Methods. Pulsed-wave Doppler recording of mitral and supe-
rior vena cava flow velocities in 20 patients with chronic obstruc-
tive pulmonary disease who had >225% respiratory variation in
mitral E-wave velocity were compared with those of 20 patients
who had surgically proved constrictive pericarditis.
Results. Constrictive pericarditis and chronic obstructive pul-
monary disease had similar respiratory variation in mitral E
velocity (41% versus 46%). In the latter, the E/A ratio was lower
(inspiration, 0.8 6 0.3 versus 1.5 6 0.7 [p < 0.0001]; expiration,
1.0 6 0.3 vs. 1.9 6 0.7 [p < 0.0001]) and deceleration time longer
(inspiration, 198 6 53 ms versus 137 6 32 ms; expiration, 225 6
43 ms vs. 161 6 33 ms [p < 0.0001]). Inspiratory superior vena
cava systolic forward flow velocity was significantly higher in
chronic obstructive pulmonary disease (72.9 6 22.6 cm/s versus
36.2 6 9.3 cm/s, p < 0.0001), while expiratory systolic forward flow
velocity was similar. Hence, there was a significantly greater
respiratory variation in superior vena cava systolic forward flow
velocity in chronic obstructive pulmonary disease without an
overlap with constrictive pericarditis (39.5 6 18.8 cm/s vs. 4.2 6
3.4 cm/s, p < 0.0001).
Conclusions. Despite a similar respiratory variation in mitral E
wave velocities, mitral inflow variables in chronic obstructive
pulmonary disease are less restrictive compared with those in
constrictive pericarditis. More importantly, patients with chronic
obstructive pulmonary disease show a marked increase in inspira-
tory superior vena cava systolic forward flow velocity, which is not
seen in patients with constrictive pericarditis.
(J Am Coll Cardiol 1998;32:2043–8)
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Respiratory variation of $25% in Doppler mitral E wave
velocity is a well-recognized diagnostic feature of constrictive
pericarditis that is useful in distinguishing pericardial constric-
tion from restrictive cardiomyopathy (1,2). However, this
respiratory variation is also found in other diseases, especially
chronic obstructive pulmonary disease. Because patients with
constrictive pericarditis and chronic obstructive pulmonary
disease can have similar clinical presentations, for example,
dyspnea and right-sided heart failure, a reliable way to differ-
entiate between these two conditions would be helpful. The
respiratory variation of mitral E velocity in chronic obstructive
pulmonary disease is related to exaggerated swings in intratho-
racic pressure with respiration (3), whereas in constrictive
pericarditis it is believed to be related to the thickened
pericardium, which prevents full transmission of intrathoracic
pressure changes to the cardiac chambers (1). Because flow
velocities in the superior vena cava are affected by the right
atrial pressure changes with respiration (4), patients with
chronic obstructive pulmonary disease should have a marked
inspiratory increase in superior vena cava forward Doppler
velocity that would not be present in patients with constrictive
pericarditis. To test this hypothesis, we designed a study to
assess the value of superior vena cava Doppler in differentiat-
ing chronic obstructive pulmonary disease from constrictive
pericarditis when the respiratory variation in mitral E velocity
was $25%.
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Methods
Patients. Twenty patients (11 males and 9 females) with
chronic obstructive pulmonary disease who were in sinus
rhythm and had $25% respiratory variation in mitral early
diastolic filling velocity (E wave) were studied. The diagnosis
of chronic obstructive pulmonary disease was based on the
clinical history and pulmonary function test (standard spirom-
etry) results, that is, forced expiratory volume in 1 s (FEV1)
,70% of predicted value or the ratio of FEV1 to forced vital
capacity (FVC) ,0.70, or both. The Doppler echocardio-
graphic measurements of mitral and superior vena cava flow
velocities were compared with those of 20 patients (19 males
and 1 female) who subsequently had surgically confirmed
constrictive pericarditis. The patients with constrictive pericar-
ditis were selected from the data base on the basis of being in
sinus rhythm, having respiratory changes in mitral E velocity of
$25%, and having superior vena cava Doppler recording for
the analysis. Two patients in the constrictive pericarditis group
had concomitant chronic obstructive pulmonary disease.
Echocardiography. All examinations were performed with
a commercially available cardiac ultrasonographic instrument,
using a 2.5- or 3.5-MHz transducer. Pulsed-wave Doppler
echocardiography was performed with simultaneous respira-
tory recording with a nasal respirometer. Mitral flow velocities
were recorded from the apical window, with a 1- to 3-mm
sample volume placed between the tips of the mitral leaflets
during diastole. Superior vena cava flow velocities were mea-
sured from the right supraclavicular fossa or suprasternal
notch. The sample volume size was 1 to 3 mm and the mean
depth of the sample volume was 5.5 6 0.3 cm. The echocar-
diogram and Doppler velocities were recorded on videotape at
recording speeds of 25, 50 and 100 mm/s.
Analysis of Doppler flow velocities. All the Doppler mea-
surements were performed manually on the still frame of the
videotape by using a built-in calculation package. Analysis of
all Doppler velocities was performed on the first cardiac cycle
after the onset of inspiration and expiration, and the values
were averaged from three respiratory cycles. From the mitral
Doppler tracing, the following variables were measured: the
peak velocity of early diastolic filling (E wave) and late filling
with atrial contraction (A wave), the E/A ratio and the
deceleration time of the E wave. From the superior vena cava
Doppler study, peak velocities and flow velocity integrals of
systolic forward, diastolic forward, end-systolic reversal and
atrial reversal waves were measured.
Statistical analysis. The effects of patient group (i.e.,
chronic obstructive pulmonary disease vs. constrictive pericar-
ditis) and respiratory phase on the echocardiographic param-
eters were investigated within the general linear mixed model
framework. In these analyses, the fixed portion of the model
consisted of the main effects for patient group and respiratory
phase as well as the interaction between these two main effects.
The interaction effect was included to test whether the changes
in echocardiographic parameter between inspiration and expi-
ration phases were consistent between the chronic obstructive
pulmonary disease and constrictive pericarditis patient groups.
To account for the possible correlation in inspiration and
expiration measurements, a random effect for subject was
incorporated into the model. Comparisons between patient
groups during inspiration or expiration were investigated
within the above general linear mixed model. All continuous
variables are expressed as mean 6 1 SD. The percentage
difference between the inspiratory and expiratory mitral Dopp-
ler measurements was calculated as a percent increase relative
to inspiration.
Results
Clinical characteristics. The mean age of the patients with
chronic obstructive pulmonary disease (63 6 10 years) and
constrictive pericarditis (58 6 12 years) was similar (p 5 0.29).
The mean heart rate was 75 6 8 beats/min for those with
chronic obstructive pulmonary disease and 77 6 10 beats/min
for those with constrictive pericarditis (p 5 0.25); the mean
respiratory rate was 20 6 4/min and 19 6 4/min (p 5 0.93),
respectively; and mean blood pressure was 101 6 13 mm Hg
and 89 6 12 mm Hg, respectively (p 5 0.0015).
The causes of chronic obstructive pulmonary disease were
chronic cigarette smoking in 18 patients, alpha1-antitrypsin
deficiency in 1 and occupational lung disease in one. Three of
the patients with a history of cigarette smoking had concomi-
tant sleep apnea and one had previous pneumonectomy be-
cause of pulmonary tuberculosis. Pulmonary function tests in
the group with chronic obstructive pulmonary disease showed
a mean FEV1 of 29% 6 16% (range, 14% to 53%) of the
predicted value and an FEV1/FVC of 0.41 6 0.18 (range, 0.19
to 0.69). Six patients with chronic obstructive pulmonary
disease underwent computed tomography of the chest, and no
pericardial thickening or calcification was noted.
The causes of constrictive pericarditis were idiopathic in
nine patients, possible viral pericarditis in five, previous cardiac
surgery in four, posttraumatic hemopericardium (after pace-
maker implantation) in one and rheumatoid arthritis in one.
Mitral doppler measurements. Table 1 compares the mi-
tral Doppler measurements for the chronic obstructive pulmo-
nary disease and constrictive pericarditis patient groups. There
were no significant interactive effects of patient group and
respiratory phase for E, A and deceleration time, indicating
that respiratory changes in these parameters were consistent
between the patient groups (p 5 0.91, 0.29, 0.82, respectively)
(Fig. 1); percent E velocity change was 46% and 41%, A
velocity change was 9% and 7% and deceleration time change
was 15% and 19% for the chronic obstructive pulmonary
disease and constrictive pericarditis groups, respectively. There
was no significant difference between patient groups in regard
Abbreviations and Acronyms
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to E velocity (p 5 0.09). However, there were significant
differences between patient groups in regard to A velocity (p 5
0.0002) and deceleration time (p 5 0.0001). The mitral E
deceleration time was shorter in the constrictive pericarditis
group (inspiration 137 6 32 ms vs. 198 6 53 ms, p , 0.0001;
expiration 161 6 33 ms vs. 225 6 43 ms, p , 0.0001).
Superior vena cava Doppler measurements. The velocities
and flow velocity intervals of the two groups of patients are
shown in Tables 2 and 3. There were significant interactive
effects of patient group and respiratory phase for systolic
forward flow (p 5 0.0001) and diastolic forward flow (p 5
0.0001) velocities. The inspiratory systolic forward flow velocity
was higher in the group with chronic obstructive pulmonary
disease (72.9 6 22.6 cm/s vs. 36.2 6 9.3 cm/s), whereas the
inspiratory diastolic forward flow velocity was similar (Fig. 2).
The expiratory diastolic forward flow velocity was significantly
lower in the chronic obstructive pulmonary disease group
(15.2 6 12.8 cm/s vs. 32.5 6 14.0 cm/s, p , 0.0018). The
absolute change in systolic and diastolic forward flow velocities
between inspiration and expiration was significantly higher in
the group with chronic obstructive pulmonary disease
(inspiratory-expiratory systolic forward flow velocity, 39.5 6
18.8 cm/s vs. 4.2 6 3.4 cm/s [p , 0.0001]; inspiratory-expiratory
diastolic forward flow velocity, 30.3 6 20.1 vs. 7.5 6 8.6 [p ,
0.0001]) (Fig. 3). Although the difference of inspiratory-
expiratory diastolic forward flow velocity was highly significant,
there was a considerable overlap between the two groups. In
contrast, the inspiratory-expiratory systolic forward flow veloc-
ity showed a minimum overlap between the two groups.
Table 1. Comparison of Mitral Doppler Measurements in Chronic
Obstructive Pulmonary Disease and Constrictive Pericarditis
Variable
Chronic
Obstructive
Pulmonary Disease
Constrictive
Pericarditis p
Inspiration
E velocity (cm/s) 52.3 6 15.8* 64.9 6 25.5* 0.1013
A velocity (cm/s) 71.2 6 16.6† 47.3 6 21.3 0.0005
E/A ratio 0.8 6 0.3* 1.5 6 0.6* , 0.0001
Deceleration time (ms) 201 6 52* 137 6 32* , 0.0001
Expiration
E velocity (cm/s) 75.2 6 22.5* 88.2 6 29.2* 0.0928
A velocity (cm/s) 76.7 6 17.5† 50.4 6 22.8 0.0001
E/A ratio 1.0 6 0.3* 1.9 6 0.7* , 0.0001
Deceleration time (ms) 226 6 43* 161 6 33* , 0.0001
Values are mean 6 SD. *p , 0.0001 inspiration vs. expiration. †p , 0.01
inspiration vs. expiration.
Figure 1. Mitral inflow Doppler from patients with chronic obstructive
pulmonary disease (COPD) (top) or constrictive pericarditis (bottom)
showing respiratory variation in mitral E velocity (arrows). ins, inspi-
ration; exp, expiration.
Table 2. Comparison of Superior Vena Cava Peak Forward and
Reverse Flow Velocity in Chronic Obstructive Pulmonary Disease
and Constrictive Pericarditis
Peak Velocity
Chronic
Obstructive
Pulmonary Disease
Constrictive
Pericarditis p
Inspiration (cm/s)
Systolic forward flow 72.9 6 22.6 36.2 6 9.3 , 0.0001
Diastolic forward flow 45.5 6 20.3 40.0 6 17.4 0.2952
End-systolic reversal 2.5 6 6.2 7.3 6 8.6 0.0700
Atrial reversal 17.9 6 7.1 12.4 6 7.8 0.0190
Expiration (cm/s)
Systolic forward flow 33.5 6 12.8 32.1 6 8.0 0.7597
Diastolic forward flow 15.2 6 12.7 32.5 6 14.0 , 0.0018
End-systolic reversal 7.7 6 9.2 8.3 6 8.3 0.8318
Atrial reversal 16.6 6 7.2 12.5 6 5.9 0.0730
Inspiration-expiration (cm/s)
Systolic forward flow 39.4 6 18.8 4.1 6 3.5 , 0.0001
Diastolic forward flow 30.3 6 20.0 7.5 6 8.6 , 0.0001
End-systolic reversal 25.2 6 9.4 21.0 6 6.1 0.0977
Atrial reversal 1.23 6 10.3 20.1 6 3.93 0.5867
Values are mean 6 SD.
Table 3. Comparison of Superior Vena Cava Forward and Reverse
Flow Velocity Integrals in Chronic Obstructive Pulmonary Disease
and Constrictive Pericarditis
Flow Velocity Integrals
Chronic
Obstructive
Pulmonary Disease
Constrictive
Pericarditis p
Inspiration (cm)
Systolic forward flow 20.2 6 7.7 6.2 6 2.3 , 0.0001
Diastolic forward flow 7.6 6 3.8 6.2 6 2.5 0.1700
End-systolic reversal 0.2 6 0.6 0.7 6 0.9 0.0955
Atrial reversal 1.9 6 1.2 1.2 6 0.9 0.0247
Expiration (cm)
Systolic forward flow 8.2 6 4.0 5.1 6 1.9 0.0373
Diastolic forward flow 3.0 6 3.4 4.9 6 2.3 0.0595
End-systolic reversal 0.8 6 1.0 0.7 6 0.9 0.8193
Atrial reversal 1.5 6 0.7 1.3 6 0.8 0.5587
Inspiration-expiration (cm)
Systolic forward flow 12.0 6 7.1 1.2 6 1.2 , 0.0001
Diastolic forward flow 4.5 6 6.0 1.3 6 1.3 0.0228
End-systolic reversal 20.5 6 1.0 0 6 0.5 0.0402
Atrial reversal 0.5 6 1.6 0 6 0.5 0.1706
Values are mean 6 SD.
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Discussion
Hemodynamics and Doppler echocardiographic features of
constrictive pericarditis and chronic obstructive pulmonary
disease. The echocardiographic diagnosis of constrictive peri-
carditis has been enhanced by incorporating the characteristic
Doppler feature of respiratory variation of mitral inflow E
velocity, as described by Hatle et al. (1). However, other
conditions can cause a similar respiratory variation in the
Doppler mitral E wave velocity, including cardiac tamponade
(5), acute right ventricular dilatation due to right ventricular
infarction or pulmonary embolism and chronic obstructive
pulmonary disease (1). Most of these conditions can be
distinguished by clinical and morphological echocardiographic
features (i.e., presence of a pericardial effusion or markedly
dilated right ventricle). However, it often is difficult to distin-
guish chronic obstructive pulmonary disease from constriction
when they have similar clinical presentations. Hoit et al. (3)
reported increased respiratory Doppler variation in mitral and
tricuspid flow in chronic lung disease, and emphasized the
importance of identifying this condition as a cause of such
respiratory change in Doppler flow velocities to avoid un-
necessary investigation and procedures. Oh et al. (2) reported
the diagnostic role of Doppler echocardiography in constric-
tive pericarditis. In that study of 23 patients with preoperative
Doppler echocardiographic findings of constrictive pericardi-
tis, 22 patients had constrictive pericarditis confirmed intraop-
eratively. One patient with normal pericardium at surgery had
severe chronic obstructive pulmonary disease that might have
been the cause of the false-positive Doppler diagnosis of
constriction.
The mechanism for respiratory variation in Doppler mitral
E wave velocity in these two groups of patients is different.
Under normal circumstances, the inspiratory fall in intratho-
racic pressure is accompanied by a decrease in intrapericardial
and intracardiac pressures of similar magnitude. However, in
constrictive pericarditis, there is a dissociation of intrapleural
and intracardiac pressures thought to be due to a thickened
and sometimes calcified pericardium, which prevents full
transmission of intrathoracic pressure changes with respira-
tion to the cardiac chambers (1). As a result, the pressure
gradient, hence, flow velocity, from the pulmonary veins to
the left atrium and to the left ventricle is decreased with
inspiration.
Airway obstruction with increased respiratory effort can
exaggerate the decrease in systemic blood pressure and result
in pulsus paradoxus during inspiration (6). It is postulated that
the exaggerated swings in intrathoracic pressures with respira-
tion are the cause of such findings. Blaustein et al. (7)
demonstrated that during induced bronchospasm or increased
resistance to breathing, intrapleural pressure becomes more
negative during inspiration and less negative or even positive
during expiration. The more negative inspiratory intrapleural
pressure results in two consequences. First, increased venous
return to the right cardiac chambers shifts the interventricular
septum to the left and decreases left ventricular end-diastolic
Figure 2. Superior vena cava Doppler from a patient with constrictive
pericarditis shows little respiratory changes in systolic forward flow
velocity (bottom) from inspiration to expiration (arrows), in contrast to
marked phasic inspiratory augmentation of forward flow velocity in
chronic obstructive pulmonary disease (COPD) (top). S, systolic
forward flow; D, diastolic forward flow; ins, inspiration; exp, expira-
tion.
Figure 3. Difference between inspiratory and expiratory
systolic forward flow velocity (left) and diastolic forward
flow velocity (right) in chronic obstructive pulmonary
disease (COPD) and constrictive pericarditis patients.
SVC, superior vena cava.
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volume and compliance (8). Similar changes together with
respiratory mitral and tricuspid Doppler E velocity variation
have been observed in patients with sleep apnea during the
episodes of sleep-associated airway obstruction (9). Second,
the negative intrapleural pressure also increases left ventricu-
lar afterload by increasing aortic transmural pressure (10).
This may also result in respiratory changes in left ventricular
output and pressure.
The superior vena cava is an intrathoracic structure, and its
flow velocities have been documented to correlate with right
atrial pressure (11). Hence, Doppler echocardiographic re-
cording from the superior vena cava usually shows an increase
in the forward flow velocity during inspiration (12). Because
restriction to cardiac filling and dissociation of intrapleural and
intracardiac pressure causes right atrial pressure to remain
increased and constant throughout the respiratory cycle in
constrictive pericarditis (13), the respiratory change in superior
vena cava forward flow velocity is minimal (14,15). However, in
patients with chronic obstructive pulmonary disease, increased
swings in intrapleural pressure cause the right atrial pressure to
decrease more than usual during inspiration, which results in
augmentation of superior vena cava forward flow velocities
toward the right atrium. As demonstrated by Izumi et al. (16),
patients with pulmonary disease showed significantly more
negative pleural pressure during inspiration in comparison
with healthy subjects, and the velocity of systolic and
diastolic forward flow during inspiration in patients with
pulmonary disease was significantly higher than that of
normal subjects. In the present study, all 20 patients with
constrictive pericarditis had minimal respiratory variation in
the superior vena cava systolic and diastolic forward flow
velocities. In comparison, 19 of the 20 patients (95%) with
chronic obstructive pulmonary disease had respiratory vari-
ation in systolic forward flow velocity of $20 cm/s, or greater
than 35% increase in the velocity with inspiration. The
patient whose systolic forward velocity had a respiratory
variation ,20 cm/s (5 cm/s) had paradoxical diaphragmatic
motion due to very severe lung hyperinflation. In a study of
patients with severe pulmonary emphysema, the correlation
between transdiaphragmatic pressure (abdominal pressure
minus pleural pressure) and respiratory variation of the
superior vena cava Doppler systolic forward flow velocity
was high (r 5 0.88, p 5 0.0002) (17). When the severity of
chronic obstructive pulmonary disease, especially pulmo-
nary emphysema, is very far advanced and diaphragmatic
dysfunction develops, the respiratory variation in superior
vena cava systolic forward flow velocity will become less
than expected.
Conclusions
In patients with chronic obstructive pulmonary disease,
respiratory variation of the mitral E velocity may be similar in
magnitude to that of patients with constrictive pericarditis.
Although patients with constrictive pericarditis are more likely
to exhibit restrictive mitral inflow characteristics (E/A .1.5
and deceleration time ,160 ms) than patients with chronic
obstructive pulmonary disease, there is sufficient overlap that
these variables cannot be used alone in individual cases. In
contrast, the superior vena cava Doppler flow velocity pattern
is distinctly different between chronic obstructive pulmonary
disease and constrictive pericarditis, with constrictive pericar-
ditis patients showing minimal augmentation of superior vena
cava inspiratory flow, and those with chronic obstructive
pulmonary disease showing exaggerated increases in inspira-
tory flow. This variable, especially respiratory variation of
systolic forward flow velocity, shows minimal overlap be-
tween the two diseases, with the rare exception of patients
with such hyperinflated lungs that there is paradoxical
diaphragmatic motion. Therefore, recording of superior
vena cava Doppler flow velocities should be an essential part
of a complete Doppler echocardiographic investigation of
constrictive pericarditis. The finding of significant inspira-
tory accentuation of superior vena cava forward flow veloc-
ities would avoid a false-positive Doppler echocardiographic
diagnosis of constriction in patients with chronic obstructive
pulmonary disease.
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